AbbVie secures FDA approval for Rinvoq as the first oral Janus kinase inhibitor indicated for giant cell arteritis, expanding ...

RO is a DTP telehealth company that provides nationwide services. The company offers multiple GLP-1 options and has hired a ...

After announcing successful trial results for its lead mRNA treatment earlier this year, Regulus Therapeutics agreed to be ...

The Zensights Federated Healthcare Advisory Panel explores how shifting global dynamics are reshaping access and strategic ...

Sheeran continues the conversation on the collaboration between AWS and EVERSANA in the second part of this interview.

Capan discusses the collaboration between AWS and EVERSANA in the first part of this two-part interview.

Market access is about aligning internal strategies with external realities that often change without warning and at a ...

Doug Long, VP, industry relations, IQVIA, examines shifting pharmaceutical trends, including specialty growth, biosimilar ...

Fran Gregory, VP, emerging therapies, Cardinal Health, discusses the evolving cell and gene therapy landscape, highlighting ...

The famous trees, and the festival associated with their blossoming each spring, is part of a tradition for the global ...

A panel of experts examines how stakeholders can support strategies that improve patient outcomes, while also navigating ...

IQVIA’s Doug Long offers a lay of the land, including trends and developing issues that are shaping the current market. The second day of Asembia’s AXS25 Summit here in Las Vegas started off with a ...